Literature DB >> 8094855

Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products.

R A Koopmans, D K Li, G Zhu, P S Allen, A Penn, D W Paty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8094855     DOI： 10.1016/0140-6736(93)90391-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

2.  Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus.

Authors:  J S Axford; F A Howe; C Heron; J R Griffiths
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

Authors:  I Mader; W Roser; L Kappos; G Hagberg; J Seelig; E W Radue; W Steinbrich
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 4.  Proton magnetic resonance spectroscopy in brain white matter disorders.

Authors:  N De Stefano; A Federico; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

5.  Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder.

Authors:  T Kato; H Hamakawa; T Shioiri; J Murashita; Y Takahashi; S Takahashi; T Inubushi
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

6.  JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Authors:  Shruti P Agnihotri; Xin Dang; Jonathan L Carter; Terry D Fife; Evelyn Bord; Stephanie Batson; Igor J Koralnik
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910

7.  Metabolic profile of PML lesions in patients with and without IRIS: an observational study.

Authors:  Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Robert E Lenkinski; Igor J Koralnik
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

8.  Imaging neuroinflammation? A perspective from MR spectroscopy.

Authors:  Natalie M Zahr; Dirk Mayer; Torsten Rohlfing; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Brain Pathol       Date:  2014-11       Impact factor: 6.508

9.  Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).

Authors:  Ruth Schneider; Barbara Bellenberg; Robert Hoepner; Eva-Maria Kolb; Gisa Ellrichmann; Aiden Haghikia; Ralf Gold; Carsten Lukas
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

10.  Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations.

Authors:  P A Brex; G J Parker; S M Leary; P D Molyneux; G J Barker; C A Davie; A J Thompson; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.